The Innovation Ecosystem Behind COVID Vaccines is Now Targeting HIV/AIDS
June marked the 40th anniversary of the first reported AIDS case. On the anniversary, UNAIDS released a strategy to end HIV/AIDS by 2030, a goal that seemed unthinkable over 40 years ago. Yet since...
View ArticleFDA Approves New Labeling for Merck Blockbuster HIV Drug ISENTRESS
This newly approved, updated prescribing information for ISENTERSS now includes 240-week results from the STARTMRK study, the double-blind Phase III study that evaluated integrase inhibitor in...
View ArticleThe Importance of Protecting Incremental, Improvement Innovation
Innovation provides new therapies and breakthrough treatments that extend and enhance life. The scientific and financial resources required for these advances are an investment worth making and an...
View ArticlePatents, Drugs and the Moral High Ground
There are millions and millions of people dying each year from all kinds of illnesses that are easily preventable using simple technologies and drugs that are off patent. None of the zealots or patent...
View ArticleExamining the Truvada #BreakThePatent Debate: Gilead Responds
In July 2012, the U.S. Food and Drug Administration (FDA) first approved Truvada, an acquired immunodeficiency syndrome (AIDS) treatment manufactured by Gilead Sciences as a daily pre-exposure...
View ArticleHouse Drug Pricing Hearing Goes Off Script
Most Congressional hearings are morality plays designed to reach a predetermined outcome. It wasn't hard to predict how the second hearing on drug pricing by the House Committee on Oversight and Reform...
View Article
